158 related articles for article (PubMed ID: 9667743)
1. Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene.
Gressani KM; Rollins LA; Leone-Kabler S; Cline JM; Miller MS
Carcinogenesis; 1998 Jun; 19(6):1045-52. PubMed ID: 9667743
[TBL] [Abstract][Full Text] [Related]
2. Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene.
Wessner LL; Fan M; Schaeffer DO; McEntee MF; Miller MS
Carcinogenesis; 1996 Jul; 17(7):1519-26. PubMed ID: 8706258
[TBL] [Abstract][Full Text] [Related]
3. Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene.
Gressani KM; Leone-Kabler S; O'Sullivan MG; Case LD; Malkinson AM; Miller MS
Carcinogenesis; 1999 Nov; 20(11):2159-65. PubMed ID: 10545420
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of transplacentally induced mouse lung tumors.
Miller MS; Leone-Kabler S; Rollins LA; Wessner LL; Fan M; Schaeffer DO; McEntee MF; O'Sullivan MG
Exp Lung Res; 1998; 24(4):557-77. PubMed ID: 9659583
[TBL] [Abstract][Full Text] [Related]
5. Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors.
Leone-Kabler S; Wessner LL; McEntee MF; D'Agostino RB; Miller MS
Carcinogenesis; 1997 Jun; 18(6):1163-8. PubMed ID: 9214598
[TBL] [Abstract][Full Text] [Related]
6. Alterations at the Ink4a locus in transplacentally induced murine lung tumors.
Mizesko MC; Grewe C; Grabner A; Miller MS
Cancer Lett; 2001 Oct; 172(1):59-66. PubMed ID: 11595130
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor suppressor genes in transplacental lung carcinogenesis.
Rollins LA; Leone-Kabler S; O'Sullivan MG; Miller MS
Mol Carcinog; 1998 Mar; 21(3):177-84. PubMed ID: 9537649
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters.
Miller MS; Gressani KM; Leone-Kabler S; Townsend AJ; Malkinson AM; O'Sullivan MG
Exp Lung Res; 2000 Dec; 26(8):709-30. PubMed ID: 11195466
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
11. No consistent pattern of mutations in p53 and ras genes in liver tumors of rat treated with the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX).
Komulainen H; Hakulinen P; Servomaa K; Makkonen K; Vasara R; Mäki-Paakkanen J; Kosma VM
Environ Mol Mutagen; 2000; 36(4):292-300. PubMed ID: 11152562
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
[TBL] [Abstract][Full Text] [Related]
13. Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene.
Hayashi S; Mori I; Nonoyama T; Mitsumori K
Toxicol Pathol; 1998; 26(4):556-61. PubMed ID: 9715515
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the mutations of p53 suppressor gene and Ha- and Ki-ras oncogenes in malignant mesothelioma in relation to asbestos exposure: a study of 12 American patients.
Kitamura F; Araki S; Suzuki Y; Yokoyama K; Tanigawa T; Iwasaki R
Ind Health; 2002 Apr; 40(2):175-81. PubMed ID: 12064559
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in HCA-induced tumors.
Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific activating mutations of Ha- and Ki-ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposure to DMBA.
Loktionov A; Hollstein M; Martel N; Galendo D; Cabral JR; Tomatis L; Yamasaki H
Mol Carcinog; 1990; 3(3):134-40. PubMed ID: 1973614
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
[TBL] [Abstract][Full Text] [Related]
18. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
19. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK
Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in the Catnb gene but not the H-ras gene in hepatocellular neoplasms and hepatoblastomas of B6C3F(1) mice following exposure to diethanolamine for 2 years.
Hayashi SM; Ton TV; Hong HH; Irwin RD; Haseman JK; Devereux TR; Sills RC
Chem Biol Interact; 2003 Dec; 146(3):251-61. PubMed ID: 14642737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
